Sort
261,768 grants matching “gene therapy”
Primary Immune Deficiency Treatment Consortium
$1,846,257Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2023 · AI
Primary Immune Deficiency Treatment Consortium
$1,846,257Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2022 · AI
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,248Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
$1,846,196Carlos Cruchaga · Washington University · R01 · FY2022 · AG
Pharmacogenetics of Nicotine Addiction and Treatment
$1,846,187Neal L Benowitz · University Of California, San Francisco · U01 · FY2008 · DA
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,173Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,173Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2018 · CA
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,846,173Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Human Artificial Chromosomes for Cancer Research and Functional Genomics
$1,845,857Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,845,849Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Aging Well, Sleeping Efficiently
$1,845,550Timothy H. Monk · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · AG
Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates
$1,845,438Tatsuo Kawai · Massachusetts General Hospital · R01 · FY2025 · AI
Role and Regulation of Cellular Polarity in Craniofacial Skeletogenesis
$1,845,189Thomas F Schilling · University Of California-Irvine · R01 · FY2025 · DE
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders
$1,845,135Christa Lese Martin · Geisinger Clinic · U01 · FY2022 · MH
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$1,845,039William C Hahn · Dana-Farber Cancer Inst · U01 · FY2017 · CA
Default mode network dysfunction in Down Syndrome
$1,844,755Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · RF1 · FY2023 · AG
Studies of Hereditary Neurological Disease: Disease Mechanisms
$1,844,566Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Autoantibodies in Preeclampsia: Pre-symptomatic markers and therapeutic targets
$1,844,556Rodney E Kellems · University Of Texas Hlth Sci Ctr Houston · RC4 · FY2010 · HD
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance
$1,844,330Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE
Human Blood-Brain Barrier Model for CNS Drug Translation
$1,844,274Eric V Shusta · University Of Wisconsin-Madison · RC4 · FY2010 · AA
Molecular Diagnostics Core Laboratory
$1,844,045Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Development of a Clinical Hemoglobin Modulator
$1,843,809Susan P Perrine · Phoenicia Biosciences, Inc. · R33 · FY2021 · HL
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
$1,843,767Jianghong Rao · Stanford University · U54 · FY2019 · CA
Growth Factor Imaging
$1,843,763Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Hematopoietic Stem Cells for Transplantation
$1,843,415Johns Hopkins University · P01 · FY2004 · CA